Leukemia
Showing NaN - NaN of 86
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)
Terminated
- Leukemia
- cyclophosphamide
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 13, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH
Recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
-
San Francisco, California
- +15 more
Jun 17, 2022
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)
Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)
Terminated
- Leukemia
- rituximab
- fludarabine phosphate
-
Anniston, Alabama
- +386 more
Apr 9, 2020
Leukemia, Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)
Terminated
- Leukemia
- Lymphoma
- therapeutic allogeneic lymphocytes
- +8 more
-
Denver, Colorado
- +22 more
Apr 8, 2020
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- +4 more
- therapeutic allogeneic lymphocytes
- +6 more
-
Denver, Colorado
- +13 more
Sep 13, 2019
Cell Damage in Acute Myeloid Leukemia, Myelodysplastic
Completed
- Leukemia
- Myelodysplastic Syndromes
- cytogenetic analysis
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 30, 2017
Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic
Completed
- Leukemia
- +2 more
- Allogeneic bone marrow transplantation
- Peripheral blood stem cell transplantation
-
Birmingham, Alabama
- +44 more
Oct 24, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)
Terminated
- Chronic Myeloproliferative Disorders
- +6 more
- anti-thymocyte globulin
- +16 more
-
Portland, OregonOHSU Knight Cancer Institute
Sep 25, 2017
Leukemia Trial in Portland (drug, radiation, other)
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- therapeutic allogeneic lymphocytes
- +9 more
-
Portland, OregonKnight Cancer Institute at Oregon Health and Science University
Sep 25, 2017
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )
Completed
- Chronic Myeloproliferative Disorders
- +9 more
- baclofen/amitriptyline/ketamine gel
- placebo
-
Scottsdale, Arizona
- +164 more
Jul 25, 2017
Blood Samples From Patients onClinical Trial to CINV During HSCT
Terminated
- Breast Cancer
- +11 more
- immunoenzyme technique
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
May 7, 2017
Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Portland (moxifloxacin HCl, Placebo)
Terminated
- Breast Cancer
- +11 more
- moxifloxacin hydrochloride
- Placebo
-
Portland, OregonKnight Cancer Institute at Oregon Health and Science University
May 7, 2017